vs

Side-by-side financial comparison of Catalyst Bancorp, Inc. (CLST) and DBV Technologies S.A. (DBVT). Click either name above to swap in a different company.

DBV Technologies S.A. is the larger business by last-quarter revenue ($2.8M vs $2.7M, roughly 1.0× Catalyst Bancorp, Inc.). Catalyst Bancorp, Inc. runs the higher net margin — 17.2% vs -1195.5%, a 1212.7% gap on every dollar of revenue. On growth, DBV Technologies S.A. posted the faster year-over-year revenue change (158.8% vs 1.4%). Catalyst Bancorp, Inc. produced more free cash flow last quarter ($3.1M vs $-32.6M). Over the past eight quarters, Catalyst Bancorp, Inc.'s revenue compounded faster (12.6% CAGR vs 12.4%).

Catalyst Bancorp, Inc. is a U.S.-based financial holding company that operates community banking subsidiaries. It provides a full range of retail and commercial banking products including checking and savings accounts, small business loans, residential mortgages, personal lending, and wealth management services, primarily serving local regional markets across the U.S. with a focus on individual consumers and small business clients.

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

CLST vs DBVT — Head-to-Head

Bigger by revenue
DBVT
DBVT
1.0× larger
DBVT
$2.8M
$2.7M
CLST
Growing faster (revenue YoY)
DBVT
DBVT
+157.4% gap
DBVT
158.8%
1.4%
CLST
Higher net margin
CLST
CLST
1212.7% more per $
CLST
17.2%
-1195.5%
DBVT
More free cash flow
CLST
CLST
$35.7M more FCF
CLST
$3.1M
$-32.6M
DBVT
Faster 2-yr revenue CAGR
CLST
CLST
Annualised
CLST
12.6%
12.4%
DBVT

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CLST
CLST
DBVT
DBVT
Revenue
$2.7M
$2.8M
Net Profit
$456.0K
$-33.2M
Gross Margin
Operating Margin
20.8%
-1235.7%
Net Margin
17.2%
-1195.5%
Revenue YoY
1.4%
158.8%
Net Profit YoY
-27.2%
-8.9%
EPS (diluted)
$0.13
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLST
CLST
DBVT
DBVT
Q4 25
$2.7M
Q3 25
$2.8M
$2.8M
Q2 25
$2.8M
$1.5M
Q1 25
$2.9M
Q4 24
$2.5M
Q3 24
$3.2M
Q2 24
$2.8M
$1.2M
Q1 24
$2.1M
$1.4M
Net Profit
CLST
CLST
DBVT
DBVT
Q4 25
$456.0K
Q3 25
$489.0K
$-33.2M
Q2 25
$521.0K
$-41.9M
Q1 25
$586.0K
Q4 24
$626.0K
Q3 24
$447.0K
Q2 24
$527.0K
$-33.1M
Q1 24
$-4.7M
$-27.3M
Operating Margin
CLST
CLST
DBVT
DBVT
Q4 25
20.8%
Q3 25
21.7%
-1235.7%
Q2 25
22.5%
-2806.2%
Q1 25
24.7%
Q4 24
31.2%
Q3 24
17.6%
Q2 24
23.0%
-2914.9%
Q1 24
-284.6%
-2029.7%
Net Margin
CLST
CLST
DBVT
DBVT
Q4 25
17.2%
Q3 25
17.7%
-1195.5%
Q2 25
18.5%
-2858.4%
Q1 25
20.1%
Q4 24
25.3%
Q3 24
14.2%
Q2 24
18.7%
-2852.4%
Q1 24
-224.0%
-1943.5%
EPS (diluted)
CLST
CLST
DBVT
DBVT
Q4 25
$0.13
Q3 25
$0.13
$-0.24
Q2 25
$0.14
$-0.31
Q1 25
$0.16
Q4 24
$0.13
Q3 24
$0.11
Q2 24
$0.13
$-0.34
Q1 24
$-1.15
$-0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLST
CLST
DBVT
DBVT
Cash + ST InvestmentsLiquidity on hand
$25.2M
$69.8M
Total DebtLower is stronger
$14.7M
Stockholders' EquityBook value
$81.7M
$52.9M
Total Assets
$282.9M
$110.5M
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLST
CLST
DBVT
DBVT
Q4 25
$25.2M
Q3 25
$37.3M
$69.8M
Q2 25
$40.1M
$103.2M
Q1 25
$40.3M
Q4 24
$44.3M
Q3 24
$45.8M
Q2 24
$75.5M
$66.2M
Q1 24
$76.0M
$101.5M
Total Debt
CLST
CLST
DBVT
DBVT
Q4 25
$14.7M
Q3 25
$14.7M
Q2 25
Q1 25
Q4 24
$9.6M
Q3 24
$29.5M
Q2 24
$30.3M
Q1 24
$29.4M
Stockholders' Equity
CLST
CLST
DBVT
DBVT
Q4 25
$81.7M
Q3 25
$81.6M
$52.9M
Q2 25
$80.8M
$86.2M
Q1 25
$80.6M
Q4 24
$80.2M
Q3 24
$81.7M
Q2 24
$81.0M
$79.1M
Q1 24
$81.3M
$111.7M
Total Assets
CLST
CLST
DBVT
DBVT
Q4 25
$282.9M
Q3 25
$283.8M
$110.5M
Q2 25
$273.8M
$143.4M
Q1 25
$271.6M
Q4 24
$276.7M
Q3 24
$280.6M
Q2 24
$295.3M
$114.2M
Q1 24
$282.0M
$145.9M
Debt / Equity
CLST
CLST
DBVT
DBVT
Q4 25
0.18×
Q3 25
0.18×
Q2 25
Q1 25
Q4 24
0.12×
Q3 24
0.36×
Q2 24
0.37×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLST
CLST
DBVT
DBVT
Operating Cash FlowLast quarter
$3.3M
$-32.4M
Free Cash FlowOCF − Capex
$3.1M
$-32.6M
FCF MarginFCF / Revenue
116.8%
-1173.5%
Capex IntensityCapex / Revenue
7.1%
4.2%
Cash ConversionOCF / Net Profit
7.21×
TTM Free Cash FlowTrailing 4 quarters
$5.4M
$-138.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLST
CLST
DBVT
DBVT
Q4 25
$3.3M
Q3 25
$912.0K
$-32.4M
Q2 25
$1.2M
$-33.9M
Q1 25
$427.0K
Q4 24
$3.2M
Q3 24
$896.0K
Q2 24
$1.4M
$-35.1M
Q1 24
$247.0K
$-34.7M
Free Cash Flow
CLST
CLST
DBVT
DBVT
Q4 25
$3.1M
Q3 25
$827.0K
$-32.6M
Q2 25
$1.1M
$-33.9M
Q1 25
$361.0K
Q4 24
$2.7M
Q3 24
$771.0K
Q2 24
$1.2M
$-35.8M
Q1 24
$223.0K
$-36.0M
FCF Margin
CLST
CLST
DBVT
DBVT
Q4 25
116.8%
Q3 25
29.9%
-1173.5%
Q2 25
39.7%
-2316.5%
Q1 25
12.4%
Q4 24
110.9%
Q3 24
24.5%
Q2 24
41.5%
-3084.0%
Q1 24
10.7%
-2560.6%
Capex Intensity
CLST
CLST
DBVT
DBVT
Q4 25
7.1%
Q3 25
3.1%
4.2%
Q2 25
1.2%
2.2%
Q1 25
2.3%
Q4 24
17.4%
Q3 24
4.0%
Q2 24
8.0%
63.0%
Q1 24
1.1%
94.9%
Cash Conversion
CLST
CLST
DBVT
DBVT
Q4 25
7.21×
Q3 25
1.87×
Q2 25
2.21×
Q1 25
0.73×
Q4 24
5.07×
Q3 24
2.00×
Q2 24
2.64×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons